Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T06:16:52.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.7%
    Check dated 2024-08-14T00:35:23.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-07-30T23:04:18.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-07-25T17:56:07.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 4 more conditions and noting that the study now includes 21 locations, while the previous version v2.9.7 has been removed.
    Difference
    1%
    Check dated 2024-07-23T14:58:29.000Z thumbnail image
  9. Check
    51 days ago
    Change Detected
    Summary
    The website has updated the 'Last Update Posted' section, removing the 'Estimated' qualifier.
    Difference
    0.0%
    Check dated 2024-07-22T14:01:51.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.